Biocept Profit Margin

The latest profit margin for BIOC is 1015.77% as of June 2023. That compares with -17.29% in the prior-year period — up 5975.5% year over year. That is above the Healthcare sector average of 21.34%. Investors often review this figure alongside Biocept's historical trend and sector peers before judging valuation or financial health.

Over the past year, BIOC's profit margin moved from -17.29% to 1015.77% — a 5975.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biocept's valuation or profitability profile.

Against Healthcare companies, BIOC currently prints 1015.77% for profit margin, while the sector average sits near 21.34%. That is roughly 4661.0% above the sector mean. Large gaps often invite a closer look at Biocept's growth, margins, and balance sheet.

Profit Margin shows how effectively Biocept converts resources into returns. At 1015.77%, BIOC may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -17.29% in the prior-year period — up 5975.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BIOC's profit margin (1015.77%), review year-over-year change from -17.29%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.